Age-related changes in the antidepressant-like effect of desipramine and fluoxetine in the rat forced-swim test

• Published in: Behavioural pharmacology Vol. 27; no. 1; p. 22
• Main Authors: Olivares-Nazario, Maribel, Fernández-Guasti, Alonso, Martínez-Mota, Lucía
• Format: Journal Article
• Language: English
• Published: England 01.02.2016
• Subjects: Aging - drug effects; Aging - physiology; Aging - psychology; Animals; Antidepressive Agents - pharmacology; Depressive Disorder - drug therapy; Depressive Disorder - physiopathology; Desipramine - pharmacology; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine - pharmacology; Male; Motor Activity - drug effects; Motor Activity - physiology; Random Allocation; Rats, Wistar; Rotarod Performance Test; Swimming - physiology; Swimming - psychology
• ISSN: 1473-5849
• DOI: 10.1097/FBP.0000000000000175

Some reports suggest that older patients are less responsive to antidepressants than young adults, but this idea has not been fully supported. Here, we investigated the role of aging in the behavioral effects of the antidepressants, desipramine (DMI) (5, 10, and 20 mg/kg) and fluoxetine (FLX) (5, 10, and 20 mg/kg) in young adults (3-5 months), middle-aged (MA, 12-15 months), and senescent (SE, 23-25 months) male rats in the forced-swim test. In addition, locomotor activity and motor coordination were assessed as side-effects. DMI and fluoxetine produced an antidepressant-like effect in YA and MA animals, although in the latter group, a shift to the right in the dose-response curve was found for DMI. Importantly, neither drug was effective in SE animals. Motor side-effects were produced mainly by DMI in MA and SE rats. Therefore, a decrease in the antidepressant-like effect is associated strongly with senescence as well as an increased vulnerability to motor side-effects, particularly of tricyclics. This study is significant because SE animals are scarcely studied in pharmacological screening tests, and our findings might be useful for improving antidepressant treatments for the increasing aged population.